Neuberger Berman Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

  • $118 Billion
  • Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 451,684 shares of REGN stock, worth $443 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
451,684
Holding current value
$443 Million
% of portfolio
0.37%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$902.69 - $993.35 $408 Million - $449 Million
451,684 New
451,684 $435 Million
Q4 2023

Feb 09, 2024
SELL
$775.18 - $881.7 $188 Million - $213 Million
-241,922 Reduced 34.18%
465,889 $409 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $589,967 - $719,403
-852 Reduced 0.12%
707,811 $583 Million
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $13.8 Million - $16.4 Million
19,784 Added 2.87%
708,663 $509 Million
Q1 2023

May 12, 2023
BUY
$680.49 - $826.97 $26.7 Million - $32.4 Million
39,229 Added 6.04%
688,879 $566 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $41.2 Million - $44.8 Million
58,411 Added 9.88%
649,650 $469 Million
Q3 2022

Nov 15, 2022
SELL
$573.97 - $724.32 $28.8 Million - $36.3 Million
-50,160 Reduced 7.82%
591,239 $407 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $24.6 Million - $33.2 Million
44,875 Added 7.52%
641,399 $379 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $1.97 Million - $2.31 Million
-3,308 Reduced 0.55%
596,524 $415 Million
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $21.9 Million - $27 Million
40,234 Added 7.19%
599,832 $378 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $100 Million - $119 Million
-174,484 Reduced 23.77%
559,598 $338 Million
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $10.3 Million - $12.1 Million
-21,707 Reduced 2.87%
734,082 $410 Million
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $85 Million - $104 Million
190,230 Added 33.64%
755,789 $357 Million
Q4 2020

Feb 10, 2021
BUY
$478.3 - $607.98 $15.9 Million - $20.2 Million
33,295 Added 6.26%
565,559 $273 Million
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $7.57 Million - $9.15 Million
-13,899 Reduced 2.54%
532,264 $298 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $26.4 Million - $34.4 Million
53,421 Added 10.84%
546,163 $340 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $58.6 Million - $86.2 Million
174,305 Added 54.74%
492,742 $241 Million
Q4 2019

Feb 12, 2020
BUY
$274.13 - $376.51 $2.04 Million - $2.8 Million
7,441 Added 2.39%
318,437 $120 Million
Q3 2019

Nov 13, 2019
SELL
$273.46 - $318.39 $823,388 - $958,672
-3,011 Reduced 0.96%
310,996 $86.3 Million
Q2 2019

Aug 13, 2019
SELL
$299.6 - $414.82 $63,515 - $87,941
-212 Reduced 0.07%
314,007 $98.3 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $415,985 - $491,439
1,118 Added 0.36%
314,219 $129 Million
Q4 2018

Feb 12, 2019
SELL
$335.82 - $403.04 $1.08 Million - $1.3 Million
-3,217 Reduced 1.02%
313,101 $117 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $6.41 Million - $7.45 Million
18,246 Added 6.12%
316,318 $128 Million
Q2 2018

Aug 13, 2018
BUY
$284.6 - $344.99 $928,080 - $1.13 Million
3,261 Added 1.11%
298,072 $103 Million
Q1 2018

May 08, 2018
BUY
$315.82 - $393.78 $1.91 Million - $2.38 Million
6,053 Added 2.1%
294,811 $102 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $1.12 Million - $1.47 Million
-3,120 Reduced 1.07%
288,758 $109 Million
Q3 2017

Nov 15, 2017
BUY
$431.38 - $504.0 $126 Million - $147 Million
291,878
291,878 $131 Million

Others Institutions Holding REGN

# of Institutions
1,426
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $105B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email